Uslu, S. Et Al. 2024. Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis. Journal of Clinical Medicine , vol.13, no.23 .

Uslu, S., Gülle, S., ŞEN, G., ÇAPAR, S., Senel, S., DALKILIÇ, H. E., ... Akar, S.(2024). Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis. Journal of Clinical Medicine , vol.13, no.23.

Uslu, Sadettin Et Al. "Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis," Journal of Clinical Medicine , vol.13, no.23, 2024

Uslu, Sadettin Et Al. "Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis." Journal of Clinical Medicine , vol.13, no.23, 2024

Uslu, S. Et Al. (2024) . "Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis." Journal of Clinical Medicine , vol.13, no.23.

@article{article, author={Sadettin Uslu Et Al. }, title={Efficacy and Safety of CT-P13 as First- and Second-Line Treatment in Patients with Ankylosing Spondylitis}, journal={Journal of Clinical Medicine}, year=2024}